# Genmab A/S: Form 6-K, filed Mar 3, 2026

- Company: [Genmab A/S](/companies/gmab.md) (CIK 1434265)
- Form: 6-K
- Filed: 2026-03-03
- Accepted by EDGAR: Mar 2, 2026, 18:41 ET
- Period: 2026-03-02
- Accession: 0001434265-26-000035
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1434265/000143426526000035/gmab_20250428x6k2.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434265/000143426526000035/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434265/000143426526000035/gmab_20250428x6k2.htm

Filed Mar 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001434265-26-000035. Last ingested by Listed: Nov 13, 2026, 10:58 ET. No prices; not investment advice.
